by palligoelme@gmail.com | Jul 10, 2026 | Clinical Trials
Conditions: Solid Tumor (Phase I); RAS Mutation; CEACAM5 Interventions: Drug: Intravenous AN4035; Drug: Intravenous AN4035 followed by intravenous EGFR Inhibitor. Sponsors: Adlai Nortye Biopharma Co., Ltd. Not yet recruiting Conditions: Solid Tumor (Phase I); RAS...
by palligoelme@gmail.com | Jul 10, 2026 | Clinical Trials
Conditions: Substance Use; Children; Cultural Factors Interventions: Behavioral: Returning to the Land – Biodiverse Outdoor Setting; Behavioral: Control Sponsors: Johns Hopkins Bloomberg School of Public Health; National Institute on Drug Abuse (NIDA) Not yet...
by palligoelme@gmail.com | Jul 10, 2026 | Clinical Trials
Conditions: ERCP; Biomechanic; Musculoskeletal Disorders Interventions: Device: CAPTIV system Sponsors: Centre Hospitalier Universitaire, Amiens; Central Hospital, Nancy, France; University Hospital, Caen; Clinique de l’Europe, Amiens; Hôpital Privé...
by palligoelme@gmail.com | Jul 9, 2026 | Clinical Trials
Conditions: Cataract Interventions: Device: Smart Bed-Exit Alert System Sponsors: National Taiwan University Hospital Recruiting Conditions: Cataract Interventions: Device: Smart Bed-Exit Alert System Sponsors: National Taiwan University Hospital...
by palligoelme@gmail.com | Jul 9, 2026 | Clinical Trials
Conditions: Spinal Cord Injuries (SCI); Spinal Cord Injury; Spinal Injury Interventions: Other: Transcutaneous spinal electrical stimulation (TSES) Sponsors: University of Manitoba Recruiting Conditions: Spinal Cord Injuries (SCI); Spinal Cord Injury; Spinal Injury...
by palligoelme@gmail.com | Jul 9, 2026 | Clinical Trials
Conditions: Gastric Cancer; Gastroesophageal Junction (GEJ) Adenocarcinoma; Becotatug Vedotin; Pucotenlimab Interventions: Drug: Becotatug Vedotin (MRG003); Drug: Pucotenlimab Sponsors: West China Second University Hospital Not yet recruiting Conditions: Gastric...